Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Signs Lease on its First East Coast R&D Site

SAN FRANCISCO, March 4 - Incyte Genomics has leased space in Delawarefor its first East Coast research site, the company said on Monday.


The 50,000 square foot lab, leased from Dupont at its Newark, Del., Stine-HaskellResearchCenter, is scheduled for occupancy in March.


Financial details of the lease agreement were not disclosed.


The lab will support approximately 80 new R&D positions in 2002, with 140 new positions projected by 2004 and 200 by 2005, according to Incyte.


"Our success in attracting Incyte to Delawareis part of my administration's overall strategy to build and strengthen Delaware's offerings as a hub for biotechnology," Governor Ruth Ann Minner said in a statement.


Nearby Maryland also has its sights set on attracting biotech companies, GenomeWeb reported in November.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.